Good news IMO and sets a base for other sales if needed. By the way this exposes those who claim that the sandalwood and the coy are worthless as somewhat inaccurate in their assessments - to say the least. How is it going HT? All IMO and DYOR
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%